Stagliano Nancyinsider trades

In SEC Form 4 filings, Stagliano Nancy is listed as Director of Electra Therapeutics, Inc. (ETRA). Stagliano Nancy reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 21.

Companies and roles

Company	Role	Transactions	Last filed
ETRAElectra Therapeutics, Inc.	Director	2	Sep 21

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-21

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
ETRAElectra Therapeutics, Inc.	Sep 21	Sep 21	C	255,635	not reported	not reported	255,635	No	Form 4
ETRAElectra Therapeutics, Inc.	Sep 21	Sep 21	C · derivative	255,635	not reported	not reported	not reported	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.